Jazz Pharmaceuticals plc — Director's Dealing 2010

Aug 27, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2010-08-25

Reporting Person: ENRIGHT PATRICK G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-08-25	Phantom Stock	$	A	3045	Acquired		Common Stock (3045)	Direct
2010-08-25	Option (right to buy)	$8.23	A	12500	Acquired	2020-08-25	Common Stock (12500)	Direct

Footnotes

F1: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock. The shares of phantom stock become payable in common stock upon the tenth (10th) business day following the earlier to occur of (i) the Reporting Person's separation from service as a director or (ii) a Change of Control (as defined under the Issuer's Directors Deferred Compensation Plan).

F2: The option shares shall vest in a series of twelve (12) successive equal installments upon completion of each month of Continuous Service (as defined under the Issuer's 2007 Non-Employee Directors Stock Option Plan, as amended) over the one (1)-year period measured from August 15, 2010.